Shareholding26 Oct 2026, 04:14 pm
Medicamen Biotech: Shivalik Rasayan Acquires 3.56% Stake
AI Summary
Shivalik Rasayan Limited, along with Growel Remedies Limited (PAC), has acquired 5,00,000 equity shares, representing 3.56% of the total capital, in Medicamen Biotech Limited. This acquisition occurred through the allotment of equity shares upon conversion of fully convertible warrants on a preferential basis. Following this transaction, Shivalik Rasayan Limited's holding in Medicamen Biotech Limited increased from 40.46% to 42.57%. The total equity share capital of Medicamen Biotech Limited post-acquisition is Rs. 14,06,28,150/-.
Key Highlights
- Shivalik Rasayan acquired 5,00,000 equity shares in Medicamen Biotech.
- The acquisition represents a 3.56% stake in the target company.
- Shivalik Rasayan's total holding increased from 40.46% to 42.57%.
- The transaction was an allotment of shares upon conversion of warrants.
- This is a disclosure under SEBI (SAST) Regulations, 2011.
Price Impact
More from MEDICAMEQ